Please, set Additional Menu

Who We Are

About Us

abaxys_logo
Abaxys Therapeutics is a biopharmaceutical company aiming to accelerate the development of highly innovative programs with strong therapeutic potential

Our Vision

ABAXYS aims to become a key player and first-choice partner in the area of human CNS diseases contributing to the development of highly innovative therapeutic solutions for neurological and neurodegenerative diseases, including neuro-orphan diseases.

Our Mission

Build-up a ‘First- and Best -in-Class’ Innovative Portfolio of Medicines for Human Neurodegenerative Diseases.

ABAXYS aims to reduce significantly the time-to-clinics of preclinical programs and contribute to develop efficacious disease modifying therapies for brain neurodegenerative diseases

Our neuroscience discovery efforts identified new therapeutic strategies aiming disease-modifying interventions by small chemical molecules and gene therapies

Own technological platforms on Big-data mining, high-resolution bio-imaging and disease-modeling strengthen the pre-clinical pipeline

Abaxys Therapeutics is advancing new medicinal drugs for the treatment of human neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease

The company is at the center of a strong strategic partnership network with a constellation of top academic institutions and small biotechs in the area of neurosciences

Our Key Approach

Our strategy is based on a business model which uses the local and European top R&D ecosystem to deliver disruptive Preclinical packages contributing to High Value Pharma Therapeutic programs

1
Hit Identification

With our Data Mining approach, we are able to efficiently identify new Hits.

2
Lead Optimization

With our Big Data and Simulation approach, we are able to accelerate the Preclinical process (from 3-5 years in only 6 months) by replacing lab, in-vitro, in-vivo experience with in-sillico validation.

3
Animal Modeling

With our Bio-imaging approach, we do not have to kill the Animal Model to see the impact of a drug. Thus we are able to follow the evolution of the disease, see the impact of a molecule and better predict the efficacy in human.

Our Team

ABAXYS team has a long experience in pharmaceutical research in neurosciences and in company creation in the area of biotechnology. We have a strong commitment to capitalize the value of our team and our partners in order to deliver successful medicines to patients.

Our Team

  • /
    Javier Garcia-Ladona
    Founder & CEO
  • /
    Guillaume de Viron
    CFO
  • /
    Valentin Tonnel
    Business Developer
  • /
    Work with us
    Apply here

Our Partners